Sientra's headquarters in Goleta. Sientra breast implants will return to U.S. doctors’ offices on March 1, almost five months after the Goleta breast implant company pulled its products off the U.S. market. Sientra made the announcement early Feb. 8 before markets opened. Investors took the news with trepidation, even though the stock traded up 15…
This article is only available to Business Times subscribers
Subscribers: LOG IN or REGISTER for complete digital access.
Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists.
